ES2183734B1 - Derivados de 4-4'-bipiridil-2-2'-bisoxazoles y 4-4'-bipiridil-2-2'-bistiazoles como agentes antineoplasicos. - Google Patents

Derivados de 4-4'-bipiridil-2-2'-bisoxazoles y 4-4'-bipiridil-2-2'-bistiazoles como agentes antineoplasicos.

Info

Publication number
ES2183734B1
ES2183734B1 ES200101818A ES200101818A ES2183734B1 ES 2183734 B1 ES2183734 B1 ES 2183734B1 ES 200101818 A ES200101818 A ES 200101818A ES 200101818 A ES200101818 A ES 200101818A ES 2183734 B1 ES2183734 B1 ES 2183734B1
Authority
ES
Spain
Prior art keywords
bipiridil
bistiazoles
bisoxazoles
derivatives
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200101818A
Other languages
English (en)
Other versions
ES2183734A1 (es
Inventor
Yolanda Martin Sanchez-Cantalejo
Maria Jesus Villa Hormaeche
Beatriz Saez Pizarro
Javier Soto Romero
Miguel Fernandez Braña
Juan Carlos Lacal Sanjuan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
Universidad Europea de Madrid SA
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Universidad Europea de Madrid SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior de Investigaciones Cientificas CSIC, Universidad Europea de Madrid SA filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Priority to ES200101818A priority Critical patent/ES2183734B1/es
Publication of ES2183734A1 publication Critical patent/ES2183734A1/es
Application granted granted Critical
Publication of ES2183734B1 publication Critical patent/ES2183734B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Derivados de 4-4''-Bipiridil-2-2''-Bisoxazoles y 4-4''-Bipiridil-2- 2''-Bistiazoles como agentes antineoplásicos. La presente invención presenta nuevos derivados de 4-4''-bipiridil-2-2''- bisoxazoles y 4-4''-bipiridil-2-2''-bistiazoles de fórmula general I con actividad antiproliferativa, y concretamente, de células malignas como HT-29. Por otro lado, se indica en la presente patente el mecanismo de su producción industrial y su uso para el desarrollo de compuestos farmacéuticos para el tratamiento de tumores humanos.
ES200101818A 2001-08-02 2001-08-02 Derivados de 4-4'-bipiridil-2-2'-bisoxazoles y 4-4'-bipiridil-2-2'-bistiazoles como agentes antineoplasicos. Expired - Fee Related ES2183734B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES200101818A ES2183734B1 (es) 2001-08-02 2001-08-02 Derivados de 4-4'-bipiridil-2-2'-bisoxazoles y 4-4'-bipiridil-2-2'-bistiazoles como agentes antineoplasicos.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200101818A ES2183734B1 (es) 2001-08-02 2001-08-02 Derivados de 4-4'-bipiridil-2-2'-bisoxazoles y 4-4'-bipiridil-2-2'-bistiazoles como agentes antineoplasicos.

Publications (2)

Publication Number Publication Date
ES2183734A1 ES2183734A1 (es) 2003-03-16
ES2183734B1 true ES2183734B1 (es) 2004-06-16

Family

ID=8498615

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200101818A Expired - Fee Related ES2183734B1 (es) 2001-08-02 2001-08-02 Derivados de 4-4'-bipiridil-2-2'-bisoxazoles y 4-4'-bipiridil-2-2'-bistiazoles como agentes antineoplasicos.

Country Status (1)

Country Link
ES (1) ES2183734B1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526788A (en) * 1983-03-18 1985-07-02 American Cyanamid Company Polymeric[[(oxazolidinyl)alkyl]amino]anthraquinones
US6214852B1 (en) * 1998-10-21 2001-04-10 Bristol-Myers Squibb Company N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DESAI, SUNIL B. y col. SYNTHESIS OF SOME SCHIFF BASES, THIAZOLIDINONES AND AZETIDINONES DERIVED FROM 2,6-DIAMINOBENZO[1,2-d:4,5-d']BISTHIAZOLE AND THEIR ANTICANCER ACTIVITIES. Heterocyclic Communications, Mayo 2001, Vol. 7, Nº 1, páginas 83-90, ISSN 0793-0283. *
KOSARY, J. y col. Synthesis of pyridylthiazoles as antisecretory agents. Pharmazie, 1989, Vol. 44, Nº 3, páginas 191-193. Compuestos con RN 121608-76-2, 121608-79-5, 121633-13-4 y 121633-14-5. *
RICE, CRAIG R. y col. New multidentate ligands for supramolecular coordination chemistry: double and triple helical complexes of ligands containing pyridyl and thiazolyl donor units. J. Chem. Soc., Dalton Trans., Marzo 2001, Vol. 5, páginas 550-559, ISSN 1472-7773. Compuestos con RN 341521-28-6 y 341521-26-4; página 551, esquema 1. *

Also Published As

Publication number Publication date
ES2183734A1 (es) 2003-03-16

Similar Documents

Publication Publication Date Title
DOP2002000429A (es) Imidazotriazinas
BR0015992A (pt) Compostos, utilização dos mesmos, e, associações terapêuticas
SE0001899D0 (sv) New compounds
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
HRP20030831B1 (en) Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
CO5271691A1 (es) Nuevos compuestos
BR0111358A (pt) Compostos de tioacetamida e seu uso
NO20040096L (no) Taxol-forbedringsforbindelser
HN2002000275A (es) Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados
CY1107815T1 (el) 1,3 - διϋποκατεστημεναι και 1,3,3 -τριϋποκατεστημεναι πυρρολιδιναι ως συνδεσμικα μεσα υποδοχεως ισταμινης -3, και θεραπευτικαι εφαρμογαι των
ATE504294T1 (de) Nichtnukleosidische reverse-transkriptase-hemmer
UY27455A1 (es) Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol -3-il)- sustituidos. su obtención y uso como fármacos.
PL1809288T3 (pl) Zastosowanie pochodnych 1,4-bis-(3-aminoalkilo)piperazyny do leczenia chorób neurodegeneracyjnych
DE60143911D1 (de) Antitumorzusammensetzungen welche ecteinascidin 743 enthalten
CY1110130T1 (el) Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α.
TR200101649T2 (tr) Piperazin türevleri.
AR043660A1 (es) El tratamiento de la enfermedad de alzheimer
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
UY27018A1 (es) Derivados de la pirimidina
DK1463735T3 (da) Imidazo-2,1-B -1,3,4-thiadiazol-sulfonamider
BRPI0415123A (pt) uso de l-butilftalida e respectiva composição farmacêutica
ECSP044971A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson
DE60330391D1 (de) Cycloalken-dicarbonsäure-verbindungen als entzündungshemmende, immunmodulatorische und antiproliferative mittel
UY27451A1 (es) 2,5-diamidoindoles sustituidos y su utilización
TR200000637T2 (tr) Benzoksazin ve benzotiazin türevleri ve bunların ilaçlarda kullanımı.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20030316

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2183734B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20180807